Halozyme Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
The current Halozyme Therapeutics(HALO) stock price is $67.72, with a market capitalization of 7.99B. The stock trades at a price-to-earnings (P/E) ratio of 26.64.
On 2026-03-10, Halozyme Therapeutics(HALO) stock moved within a range of $67.14 to $68.59. With shares now at $67.72, the stock is trading +0.9% above its intraday low and -1.3% below the session's peak.
Trading activity shows a volume of 354.24K, compared to an average daily volume of 1.62M.
The stock's 52-week range extends from a low of $47.50 to a high of $82.22.
The stock's 52-week range extends from a low of $47.50 to a high of $82.22.
HALO News
In recent weeks, Halozyme Therapeutics reported record 2025 revenue of about US$1.40 billion, highlighted growing ENHANZE-driven royalties, and outlined progres...
Halozyme Therapeutics (NasdaqGS:HALO) has agreed to acquire Hypercon and several biotech startups, expanding its drug delivery and platform capabilities. The H...
Analyst ratings
56%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.